Personalized Testing and Supplements Market Size to Hit USD 39.65 Billion by 2033

Personalized Testing and Supplements Market Size, Share, Growth Trends, Segmental Analysis, Leading Company Profiles: By Service (Personalized Testing, Personalized Recommendations, Personalized Supplements), By Testing Technology (Genetic and DNA-Based Testing, Microbiome Testing, Blood Biomarker Testing, Continuous Glucose Monitoring, Comprehensive Metabolic Panel Testing, Others), By Application (Immunity and General Wellness, Digestive Health and Gut Microbiome, Weight Management and Metabolism, Sports Performance and Recovery, Cognitive Health and Mental Wellness, Skin Hair and Beauty, Others), By Distribution Channel (Direct-to-Consumer Online Platforms, Healthcare Provider and Telehealth Channels, Retail Pharmacies and Health Stores, Corporate Wellness Programs, Others), By End User (Individual Consumers, Healthcare Professionals, Corporate Wellness Programs, Athletes and Sports Professionals, Others), By Region (North America [United States, Canada, Mexico], Europe [Germany, United Kingdom, France, Italy, Netherlands, Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, Australia, Rest of Asia-Pacific], Latin America [Brazil, Argentina, Rest of Latin America], Middle East & Africa [UAE, Saudi Arabia, South Africa, Rest of MEA]) and Market Forecast, 2026 – 2033

  • Published: May, 2026
  • Report ID: 403
  • Pages: 160+
  • Format: PDF / Excel.

This report contains the Latest Market Figures, Statistics, and Data.

Get a Sample
logo

Personalized Testing and Supplements Market Size to Hit USD 39.65 Billion by 2033

(An Updated Version is Available)

1. Introduction

  • 1.1 Report Overview and Scope

  • 1.2 Market Definition

  • 1.3 Study Assumptions and Limitations

  • 1.4 Research Methodology

  • 1.4.1 Primary Research Approach

  • 1.4.2 Secondary Research Approach

  • 1.4.3 Data Triangulation and Validation

  • 1.5 List of Abbreviations and Acronyms

2. Executive Summary

  • 2.1 Market Snapshot and Key Highlights

  • 2.2 Key Market Findings and Strategic Insights

  • 2.3 Market Attractiveness Analysis by Segment

  • 2.4 Analyst Recommendations

3. Market Overview

  • 3.1 Definition and Introduction to Personalized Testing and Supplements

  • 3.2 Market Taxonomy and Scope

  • 3.3 Historical Market Evolution (2021–2025)

  • 3.4 Market Ecosystem Overview

  • 3.4.1 At-Home Diagnostic Testing (Blood, DNA, Microbiome)

  • 3.4.2 AI-Driven Supplement Personalization Platforms

  • 3.4.3 Supplement Formulation and Manufacturing

  • 3.4.4 Subscription-Based Delivery and DTC Model

  • 3.4.5 Post-Consumption Monitoring and Feedback Loops

  • 3.5 Value Chain Analysis

  • 3.5.1 Raw Material and Ingredient Suppliers

  • 3.5.2 Testing Technology Developers and Lab Partners

  • 3.5.3 Platform Operators and DTC Brands

  • 3.5.4 Dieticians, Nutritionists, and Healthcare Practitioners

  • 3.5.5 End Users (Consumers, Corporates, Clinics)

  • 3.6 Regulatory and Policy Framework

  • 3.6.1 U.S. FDA Regulations on Dietary Supplements (DSHEA Framework)

  • 3.6.2 FTC Guidelines on Personalized Health Marketing Claims

  • 3.6.3 EU Regulations (EFSA, GDPR Impact on Health Data Usage)

  • 3.6.4 Asia-Pacific Regulatory Developments (FSSAI, CFDA)

  • 3.6.5 Data Privacy Laws Governing At-Home Genetic Testing

  • 3.7 Macroeconomic Factors Influencing Market Growth

  • 3.7.1 Rise of Preventive Healthcare and Consumer Health Literacy

  • 3.7.2 Impact of Rising Healthcare Costs on Supplement Adoption

  • 3.7.3 Increased Spending on Wellness in Post-Pandemic Consumer Behavior

4. Market Dynamics

  • 4.1 Key Market Drivers

  • 4.1.1 Increasing Consumer Demand for Individualized Health Solutions

  • 4.1.2 Advancements in Genomics, Metabolomics, and Microbiome Sequencing

  • 4.1.3 Proliferation of At-Home Diagnostic Kits and Digital Health Platforms

  • 4.1.4 Growing Adoption of AI-Driven Personalization Engines and Wellness Algorithms

  • 4.1.5 Integration of Wearable Devices and Real-Time Biomarker Monitoring

  • 4.1.6 Expansion of Subscription-Based DTC Models and E-Commerce Wellness Platforms

  • 4.1.7 Corporate Wellness Programs Driving B2B Demand for Personalized Supplements

  • 4.2 Market Restraints

  • 4.2.1 Lack of Regulatory Standardization and Scientific Validation Across Regions

  • 4.2.2 High Cost of Genetic and Microbiome Testing Limiting Mass Accessibility

  • 4.2.3 Data Privacy and Cybersecurity Concerns Related to Personal Health Data

  • 4.2.4 Overpromising Marketing Claims Undermining Consumer Trust

  • 4.3 Market Opportunities

  • 4.3.1 Integration of Personalized Supplement Programs in Mainstream Retail (CVS, Walgreens, Amazon)

  • 4.3.2 Expansion of Corporate Wellness Benefits Including Subsidized Testing and Supplements

  • 4.3.3 Insurance Integration: Leveraging Personalized Nutrition to Reduce Chronic Disease Claims

  • 4.3.4 Untapped Growth Potential in Asia Pacific and Emerging Markets

  • 4.3.5 Innovations in Delivery Formats: Personalized Gummies, Patches, Nootropics, and Adaptogens

  • 4.4 Market Challenges

  • 4.4.1 Inconsistent Scientific Evidence for Some Personalization Approaches

  • 4.4.2 Managing Continuous Feedback and Dynamic Reformulation at Scale

  • 4.4.3 Interoperability of Wearable Devices and Testing Platforms

  • 4.4.4 Consumer Retention and Long-Term Subscription Fatigue

5. Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers

  • 5.2 Bargaining Power of Buyers

  • 5.3 Threat of New Entrants

  • 5.4 Threat of Substitute Products and Services

  • 5.5 Intensity of Competitive Rivalry

6. PESTEL Analysis

  • 6.1 Political Factors

  • 6.2 Economic Factors

  • 6.3 Social Factors

  • 6.4 Technological Factors

  • 6.5 Environmental Factors

  • 6.6 Legal Factors

7. Technology and Innovation Landscape

  • 7.1 Genomics and DNA-Based Personalization

  • 7.2 Microbiome and Gut Health Testing (Viome Model)

  • 7.3 Blood Biomarker and Metabolomic Analysis (Finger-Prick Kits)

  • 7.4 Epigenetic Testing and Biological Age Assessment

  • 7.5 AI and Machine Learning in Supplement Recommendation Engines

  • 7.6 Wearable Device Integration (Oura Ring, Levels Health, Samsung Galaxy Ring)

  • 7.7 Digital Twin Technology for Nutritional Modeling

  • 7.8 Cloud-Based Health Dashboards and Real-Time Monitoring Platforms

  • 7.9 Blockchain for Ingredient Traceability and Supplement Transparency

  • 7.10 Nutrigenomics and Personalized Omics Sciences

  • 7.11 3D Printing and On-Demand Supplement Manufacturing

8. Market Segmentation Analysis

8.1 By Service

  • 8.1.1 Personalized Testing

  • Blood Tests

  • DNA Tests

  • Wearable Device & App-Based Tests

  • Urine and Gut Microbiome Tests

  • Others

  • 8.1.2 Personalized Recommendations

  • Fixed Recommendations

  • Repeat Recommendations

  • Continuous / Dynamic Recommendations

  • 8.1.3 Personalized Supplements

  • Proteins and Amino Acids

  • Vitamins

  • Minerals

  • Probiotics

  • Herbal / Botanical Supplements

  • Others (Adaptogens, Nootropics, Anti-Aging Compounds)

8.2 By Service Provider

  • 8.2.1 Personalized Testing and Supplement Companies (DTC)

  • 8.2.2 Dieticians and Nutritionists

  • 8.2.3 Hospitals and Clinical Nutrition Centers

  • 8.2.4 Others

8.3 By Application

  • 8.3.1 General Health and Wellness

  • 8.3.2 Deficiency Management

  • 8.3.3 Sports and Performance Nutrition

  • 8.3.4 Weight Management and Metabolic Health

  • 8.3.5 Maternal and Prenatal Health

  • 8.3.6 Cognitive Health and Mental Wellness

  • 8.3.7 Skin, Hair, and Beauty Nutrition

  • 8.3.8 Others

8.4 By Consumer Demographics

  • 8.4.1 Millennials and Gen Z

  • 8.4.2 Adults (35–55 Years)

  • 8.4.3 Senior Population (55+ Years)

  • 8.4.4 Pediatric and Teen Segment

9. Regional Market Analysis

9.1 North America

  • 9.1.1 Market Overview, Size, and Growth Outlook

  • 9.1.2 United States

  • 9.1.3 Canada

  • 9.1.4 Mexico

9.2 Europe

  • 9.2.1 Market Overview and Regulatory Context

  • 9.2.2 United Kingdom

  • 9.2.3 Germany

  • 9.2.4 France

  • 9.2.5 Italy

  • 9.2.6 Spain

  • 9.2.7 Denmark

  • 9.2.8 Sweden

  • 9.2.9 Norway

  • 9.2.10 Rest of Europe

9.3 Asia-Pacific

  • 9.3.1 Market Overview and High-Growth Outlook

  • 9.3.2 China

  • 9.3.3 Japan

  • 9.3.4 India

  • 9.3.5 Australia

  • 9.3.6 South Korea

  • 9.3.7 Thailand

  • 9.3.8 Rest of Asia-Pacific

9.4 Latin America

  • 9.4.1 Market Overview

  • 9.4.2 Brazil

  • 9.4.3 Argentina

  • 9.4.4 Rest of Latin America

9.5 Middle East and Africa (MEA)

  • 9.5.1 Market Overview

  • 9.5.2 Saudi Arabia

  • 9.5.3 United Arab Emirates

  • 9.5.4 South Africa

  • 9.5.5 Kuwait

  • 9.5.6 Rest of Middle East and Africa

10. Competitive Landscape

  • 10.1 Market Concentration and Competitive Overview

  • 10.2 Market Share Analysis of Top Players (2025)

  • 10.3 Competitive Benchmarking Matrix

  • 10.4 Key Strategic Developments

  • 10.4.1 Mergers, Acquisitions, and Strategic Investments

  • 10.4.2 Product Launches and New Service Introductions

  • 10.4.3 Partnerships, Collaborations, and Platform Integrations

  • 10.4.4 Expansions into New Geographies and Distribution Channels

  • 10.5 Innovation and R&D Investment Analysis

  • 10.6 Patent Landscape and Intellectual Property Trends

  • 10.7 ESG and Sustainability Practices in Supplement Production

  • 10.8 DTC vs. Retail vs. Clinical Channel Share Analysis

11. Company Profiles

(The final report includes a complete list of companies)

11.1 Viome Life Sciences Inc.

  • 11.1.1 Company Overview

  • 11.1.2 Financial Performance

  • 11.1.3 Product Portfolio

  • 11.1.4 Strategic Initiatives

  • 11.1.5 SWOT Analysis

11.2 Thorne HealthTech Inc.

11.3 DSM-Firmenich (DSM Nutritional Products AG)

11.4 Nestlé Health Science S.A. (Persona Nutrition)

11.5 Pharmavite LLC (Nature Made)

11.6 Baze Personalized Nutrition

11.7 GNC Holdings Inc.

11.8 InsideTracker Inc.

11.9 Rootine Health Inc.

11.10 Bioniq Health Ltd.

11.11 Care/of (BForm Inc.)

11.12 LifeNome Inc.

11.13 Nutrigenomix Inc.

11.14 Everlywell Inc.

11.15 The Vitamin Shoppe (Franchise Group)

12. Investment and Opportunity Analysis

  • 12.1 High-Growth Segments and Investment Hotspots

  • 12.2 Venture Capital and Private Equity Activity in Personalized Nutrition

  • 12.3 Government and Institutional Funding in Precision Nutrition Research

  • 12.4 Emerging Business Models: B2B Wellness, Insurance Integration, and Employer Health Plans

  • 12.5 Strategic Recommendations for Market Stakeholders

13. Impact Analysis

  • 13.1 Impact of AI and Generative Technologies on Supplement Personalization

  • 13.2 Impact of COVID-19 on Health Awareness and Market Acceleration

  • 13.3 Impact of Data Privacy Regulations (GDPR, CCPA) on At-Home Testing Models

  • 13.4 Impact of GLP-1 Drug Adoption on Personalized Nutrition Supplement Demand

  • 13.5 Impact of Sustainability and Clean-Label Trends on Ingredient Sourcing

14. Appendix

  • 14.1 List of Tables

  • 14.2 List of Figures

  • 14.3 Research Methodology Overview

  • 14.4 Data Sources and References

  • 14.5 Glossary of Key Terms (DTC, DNA Testing, Microbiome, Metabolomics, HALEU, Nutrigenomics, etc.)

  • 14.6 About the Publisher

15. Disclaimer

Enhance your decision-making capabilities with a 5 Reports-in-1
Bundle deal for - more than 40% off!

Our professional analysts will provide you with immediate assistance.